Nursing Management Of Specific Populations Of Mental Health Practice Test

Screening and treating perinatal patients with both depression and substance use disorder should be done in a coordinated, integrated way. Start by using validated screening tools that are appropriate for pregnancy and postpartum to identify both conditions early. For depression, validated perinatal tools help detect mood symptoms that may arise or worsen during pregnancy and after delivery. For substance use, brief, standardized screens tailored to perinatal care help uncover use patterns that might not be disclosed otherwise. Using these tools together in the same care setting ensures neither condition is missed and signals when a combined treatment plan is needed. Integrated treatment means the depression and the substance use disorder are managed concurrently by a team that collaborates across obstetrics, mental health, and addiction services. This approach addresses how the disorders influence each other—depressive symptoms can amplify relapse risk, and ongoing substance use can worsen mood and complicate treatment—and it supports the patient with a unified plan. Treatment may include psychotherapy (such as cognitive-behavioral or interpersonal therapy), medication for depression when indicated and appropriate for pregnancy, and evidence-based addiction care (including medications for substance use disorders when indicated), along with social supports, safety planning, and postpartum planning. Coordinated care is essential for safety, adherence, and better outcomes for both mother and infant. Delaying treatment until after birth or separating care from obstetric services undermines safety and engagement, given the high risk of relapse and adverse maternal–infant outcomes. Coordinating with obstetrics and providing timely, integrated care helps reduce these risks and supports healthier trajectories for both mother and baby.